Properties
Description
Mobocertinib succinate is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells.
Molecular Formula
C36H45N7O8
Identity
Confirmed by NMR/HPLC/MS.
Applications
Mobocertinib succinate is used to research for its efficacy in inhibiting EGFR-HER2 activity, which is pivotal for advancing cancer treatment targeted at those specific receptors.
